Weibo Zhou

789 total citations
8 papers, 636 citations indexed

About

Weibo Zhou is a scholar working on Cancer Research, Molecular Biology and Oncology. According to data from OpenAlex, Weibo Zhou has authored 8 papers receiving a total of 636 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Cancer Research, 5 papers in Molecular Biology and 3 papers in Oncology. Recurrent topics in Weibo Zhou's work include Cancer, Lipids, and Metabolism (4 papers), Cancer-related Molecular Pathways (3 papers) and Cancer, Hypoxia, and Metabolism (3 papers). Weibo Zhou is often cited by papers focused on Cancer, Lipids, and Metabolism (4 papers), Cancer-related Molecular Pathways (3 papers) and Cancer, Hypoxia, and Metabolism (3 papers). Weibo Zhou collaborates with scholars based in United States, South Korea and China. Weibo Zhou's co-authors include Francis P. Kuhajda, P. Jeanette Simpson, Gabriele V. Ronnett, Susan M. Medghalchi, Craig A. Townsend, Michael L. Pinn, Aravinda Vadlamudi, Arumugam Nagalingam, Diansheng Zhong and Neeraj K. Saxena and has published in prestigious journals such as Cancer Research, Oncogene and American Journal Of Pathology.

In The Last Decade

Weibo Zhou

8 papers receiving 627 citations

Peers

Weibo Zhou

MB

CR

ONCOL

EPIDE

CB

Amanda Hutchins United States

Peiwei Huangyang China

Portia S. Lombardo United States

Hubert Kasperczyk Germany

G Destefanis Italy

Emily Montal United States

Sandra Mattu Italy

Ralph J. DeBerardinis United States

Niranjan Venkateswaran United States

Salvatore Delogu Germany

Amanda Hutchins United States

Weibo Zhou

482 ×1.1

MB

364 ×1.0

CR

101 ×0.8

ONCOL

76 ×0.9

EPIDE

35 ×0.5

CB

Citations per year, relative to Weibo Zhou Weibo Zhou (= 1×) peers Amanda Hutchins

Countries citing papers authored by Weibo Zhou

Since Specialization

Citations

This map shows the geographic impact of Weibo Zhou's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Weibo Zhou with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Weibo Zhou more than expected).

Fields of papers citing papers by Weibo Zhou

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Weibo Zhou. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Weibo Zhou. The network helps show where Weibo Zhou may publish in the future.

Co-authorship network of co-authors of Weibo Zhou

This figure shows the co-authorship network connecting the top 25 collaborators of Weibo Zhou. A scholar is included among the top collaborators of Weibo Zhou based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Weibo Zhou. Weibo Zhou is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

8 of 8 papers shown

1.

Zhu, Chunhui, et al.. (2021). Exosome-mediated circ_0001846 participates in IL-1β-induced chondrocyte cell damage by miR-149-5p-dependent regulation of WNT5B. Clinical Immunology. 232. 108856–108856. 30 indexed citations

2.

Zhou, Weibo, et al.. (2015). Expressions of survivin, P16(INK4a), COX-2, and Ki-67 in cervical cancer progression reveal the potential clinical application.. PubMed. 36(1). 62–8. 9 indexed citations

3.

Zhou, Weibo, et al.. (2009). Malonyl-CoA decarboxylase inhibition is selectively cytotoxic to human breast cancer cells. Oncogene. 28(33). 2979–2987. 41 indexed citations

4.

Nagalingam, Arumugam, et al.. (2009). LKB1 is required for adiponectin-mediated modulation of AMPK–S6K axis and inhibition of migration and invasion of breast cancer cells. Oncogene. 28(29). 2621–2633. 141 indexed citations

5.

Zhou, Weibo, Wan Fang Han, Leslie E. Landree, et al.. (2007). Fatty Acid Synthase Inhibition Activates AMP-Activated Protein Kinase in SKOV3 Human Ovarian Cancer Cells. Cancer Research. 67(7). 2964–2971. 129 indexed citations

6.

Zhou, Weibo, P. Jeanette Simpson, Jill M. McFadden, et al.. (2003). Fatty acid synthase inhibition triggers apoptosis during S phase in human cancer cells.. PubMed. 63(21). 7330–7. 194 indexed citations

7.

Wersto, Robert P., et al.. (2002). Variable Levels of Chromosomal Instability and Mitotic Spindle Checkpoint Defects in Breast Cancer. American Journal Of Pathology. 161(2). 391–397. 88 indexed citations

8.

Zhou, Weibo, et al.. (2002). Staurosporine-induced G 1 arrest in cancer cells depends on an intact pRB but is independent of p16 status. Cancer Letters. 183(1). 103–107. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact